Purpose of the Guideline

Size: px
Start display at page:

Download "Purpose of the Guideline"

Transcription

1 Trust Policy and Procedure Substitution of Medicines Policy Document ref. no: PP(17)210 For use in: For use by: For use for: Document owner: Status: All clinical areas Pharmacists and authorised Pharmacy Technicians For use in ensuring that Trust prescribing meets the medicines management agenda of the Trust in an efficient manner Chief Pharmacist Approved Contents Page Purpose of guideline 1 General Principles 1 Recommendation and procedures 2 1) Generic substitution 2 2) Therapeutically equivalent substitution 2 3) Rationalisation of antibiotic time of administration 2 4) Rationalisation of time of administration of other medication 3 5) Miscellaneous substitutions 4 6) Specific substitution documents 4 Documentation 4 Rational for main recommendations 4 Document configuration 5 Purpose of the Guideline This document sets out how and when a prescription for a medicine may be amended by a Pharmacist or Pharmacy Technician (who has been assessed as competent to act under this policy, after discussion with a Pharmacist) General Principles It is agreed by the Trust that under certain circumstances it is appropriate for a pharmacist to change a patient s in-patient or out-patient prescription. Any change made must not conflict with the interests of the patient and should comply with the Summary of Product Characteristics (SPC) recommendations. Examples given below are not exhaustive, they demonstrate the scope of the type of substitutions that may be made Source: Chief Pharmacist Status: Approved Page 1 of 5

2 Recommendations and procedures The change of prescription will be either:- 1. Generic Substitution A change from a branded preparation to the same generic medicine (generic substitution). Generic prescribing is the norm in hospital practice and is reflected in the contents of the Hospital Formulary and the Trust s Policy for the Use of Medicines. It is accepted that under certain circumstances generic substitution is inappropriate, particularly in areas where the bioavailability of branded and generic products differs significantly (e.g. Antiepileptics). If there is any doubt concerning the suitability of the substitution the prescriber will be contacted by the Pharmacist 2. Therapeutically Equivalent Substitution The substitution of one medicine for another therapeutically equivalent medicine. This will allow non-formulary or unavailable preparations to be substituted to rationalise stock and enable therapy to start more quickly. If there is any doubt concerning the suitability of the substitution the prescriber will be contacted by the Pharmacist:- Oral Quinine Sulphate for Quinine Bisulphate (and change of dose from 200mg to 300mg) Oral and IV/IM Amoxicillin for Ampicillin (and change from QDS to TDS, where appropriate) Oral Oxytetracycline for Tetracycline Generic Ibuprofen 5% Gel for any topical NSAID prescribed Oral Sando-K Tablets for Slow K or Effervescent Potassium Tablets (and amend dose appropriately). Peptac liquid for Gaviscon preparations 3. Rationalisation of Antibiotic Time of Administration A change of timing or frequency of administration of any antibiotic to achieve more rational drug therapy. Examples include:- Oral and IV/IM Amoxycillin from four times a day to three times a day Metronidazole Suppositories, reduce frequency of administration from three times a day to twice a day after 72 hours Amendment of the times of administration of any antibiotic prescription to ensure the prescription meets BNF prescribing frequency recommendations Source: Chief Pharmacist Status: Approved Page 2 of 5

3 4. Rationalisation of Time of Administration of Other Medication A change of timing of administration of the following products to achieve more rational drug therapy:- Oral Isosorbide Mononitrate timing of doses to 8am and 2pm for nonmodified release preparations Morphine Sulphate SR preparations - 12 hourly dosage interval Simvastatin/Pravastatin/Fluvastatin/Rosuvastatin/Bezafibrate SR timing of dose at night Phenelzine/Amantadine/Selegiline - timing of last dose of the day to 4pm Cholestyramine timing of doses to avoid other drugs whose absorption may be reduced Antacids timing of doses to avoid any other drugs whose absorption may be reduced Disodium Etidronate/Alendronate/Risedronate timing of dose to avoid food and milk for two hours before and after dose Stimulant antidepressants timing of dose to morning Alendronic acid/risedronate Frequency of once weekly doses to once a week, if inadvertently prescribed daily Alendonic acid or Risedronate once a week in combination with Calcium Carbonate indication that Calcium Carbonate is not to be taken on the same day as the Alendronic acid or Risedronate Diuretics Timing of last dose of the day, in patients without a urinary catheter, to 2pm Iron preparations Changing iron salt prescribed to Ferrous Fumarate for solid dose forms or Sodium Feredetate for liquid administration to provide the equivalent daily elemental iron intake Iron preparations - Changing of timing of doses to avoid being given at the same time of day as a quinolone antibiotic. Dipyridamole SR 200mg Capsules twice a day, changed to Dipyridamole liquid 100mg three times a day for patients with a proven swallowing deficit needing a liquid preparation Levothyroxine Change of time of administration to before breakfast Quinolone antibiotics - Amend time of administration to coincide with breaks in supplemental enteral feed regimes to reduce risk for interaction Phenytoin - Amend time of administration to coincide with breaks in supplemental enteral feed regimes to reduce risk for interaction Source: Chief Pharmacist Status: Approved Page 3 of 5

4 Insulin Patients on a twice-daily insulin regime change time of dosing to 8am and 6pm Miscellaneous Substitutions: Oral Co-Amoxiclav 375 two tablets three times a day to oral Co- Amoxiclav 625 one tablet three times a day Phenytoin Amend dose to take into account the non-bioequivalence of tablets/capsules to liquid (100mg of tablet/capsule is equivalent to 90mg of liquid) Citalopram Amend dose to take into account the non-bioequivalence of tablets to liquid (10mg tablet is equivalent to 8mg(4 drops) of liquid) Isomeric equivalent drugs Amend non-formulary isomeric drugs to the Trust formulary choice when appropriate e.g: 5mg Levocetirizine to 10mg Cetirizine 5mg Desloratidine to 10mg Loratidine Supply of spacer device for inhalers if appropriate Addition of an appropriate dose when a drug is prescribed PO/IM/IV (e.g. Domperidone, Prochlorperazine). Changing dose of oral Metronidazole 500mg three times a day to 400mg three times a day orally 5. Specific substitution policy documents For specific classes of medicines it may be appropriate for detailed substitution policy documents to be developed. These documents will state any specific detailed action that must occur when the substitution policy is used. These documents will be produced when more specific guidance is necessary to ensure that a substitution process is appropriately managed, for example when a substitution involves the change of the drug and dose to ensure equivalence. Documentation All prescriptions changed as a result of this policy must be clearly annotated as per substitution policy by the substituting pharmacist If a prescriber intentionally prescribes a particular dose regime that falls outside of the usual guidance for the particular drug, they are asked to annotate the prescription with the reason for the non-standard dosing, to ensure that the prescription is not amended under the Substitution of Medicines Policy Rationale for main recommendations This document has been developed to ensure that Pharmacists can appropriately amend a prescription written by a legal prescriber in appropriate limited situations Source: Chief Pharmacist Status: Approved Page 4 of 5

5 Document Configuration Author(s): Other contributors: Approvals and endorsements: Consultation: Issue no: 7 File name: Supersedes: Equality Assessed Implementation Monitoring: (give brief details how this will be done) Other relevant policies/documents & references: Additional Information: Simon Whitworth, Chief Pharmacist ) ) ) ) ) Drugs and Therapeutics Committee (Approved ) Medical Staff Committee (Approved ) Clinical Standards Executive Committee (Approved ) All Trust Consultants comments included All Trust Pharmacists comments included Trust Solicitors comments included H:\Personal\Simon\Policies\Substitution Policy\FINAL Substitution of Meds Policy New Trust format May 2017.doc PP(15)210 Yes To be available electronically on the West Suffolk Hospital Intranet Site and also the Pharmacy Department Intranet policy section This policy will be monitored by periodic prescription audit Substitution of medicines policy, West Suffolk Formulary Review Group, March 1996 This document has been updated to reflect current practice. Source: Chief Pharmacist Status: Approved Page 5 of 5

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy Document ref. no: Trust Policy and Procedure PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy For use in: For use by: For use for: Document owner: Status: All Clinical Areas

More information

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority

More information

Found in practice. Joint Formulary. Joint Formulary. Embedded into practice. Embedded into practice. As above. As above.

Found in practice. Joint Formulary. Joint Formulary. Embedded into practice. Embedded into practice. As above. As above. IPSWICH HOSPITAL ADULT THERAPEUTIC SUBSTITUTION REGISTER FOR PHARMACISTS What s New? New Substitutions Added exclusion criteria of Recommended by psychiatry to escitalopram switch Enoxaparin 40mg to 20mg

More information

NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09

NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09 Title of Project: NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09 1 Reason for the review Choice of iron preparation is based on cost and incidence of side effects (BNF). There is little

More information

Brand and Generic Drugs. Educational Objectives. Absorption

Brand and Generic Drugs. Educational Objectives. Absorption Peter J. Rice, PharmD, PhD Associate Professor of Pharmacology East Tennessee State University Educational Objectives Pharmacokinetic Processes Distribution Metabolism Excretion Similarities Active ingredient(s)

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

London Medicines Information Service

London Medicines Information Service London Medicines Information Service Extended-release methylphenidate a review of the pharmacokinetic profiles available March 2018 First authored by Martin Bradley (martin.bradley@gstt.nhs.uk) May 2016

More information

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION CLASSIFICATION OF DOCUMENT: PURPOSE: Patient Group Direction Document

More information

SHARED CARE GUIDELINE

SHARED CARE GUIDELINE SHARED CARE GUIDELINE Title: Lithium Treatment in Adults aged 18-65 years Scope: Pennine Care NHS Foundation Trust NHS Bury NHS Oldham NHS Heywood, Middleton and Rochdale NHS Stockport NHS Tameside & Glossop

More information

MODULE 1: BASIC DRUG KNOWLEDGE

MODULE 1: BASIC DRUG KNOWLEDGE MODULE 1: BASIC DRUG KNOWLEDGE 1.1 How Drugs Work A drug is a medicine or substance (but not food or water) which when ingested (or otherwise introduced into the body) alters the way the body works physically

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13 BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 BNF 1.1 ANTACIDS Mucogel and Peptac are effective antacids and are available over the counter Gaviscon / Gaviscon Advance are available over the counter First

More information

Unit 204 Assist with the assembly of prescribed items

Unit 204 Assist with the assembly of prescribed items Element 1 Assemble prescribed 171 172 Element 1 Assemble prescribed Background Assembling prescribed is a complex process. The two main components of this process are labelling and dispensing. It is essential

More information

PATIENT GROUP DIRECTION PROCEDURE

PATIENT GROUP DIRECTION PROCEDURE PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen

More information

Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults

Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults Ref: PHARM-0025-v3 Status: FINAL Document type: Guidelines Guidance on Safe Prescribing of Melatonin Page

More information

Good Practice Guidance on Covert Administration of Medication

Good Practice Guidance on Covert Administration of Medication Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their

More information

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply

More information

The Society welcomes the opportunity to respond the Department of Health s consultation on generic substitution.

The Society welcomes the opportunity to respond the Department of Health s consultation on generic substitution. Lindsey Gilpin Chairman of the English Pharmacy Board Telephone: 020 7572 2519 Fax: 0207 572 2501 e-mail: howard.duff@rpsgb.org 25 th March 2010 Dear Sir/Madam, Consultation on the proposals to implement

More information

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression SHARED CARE PROTOCOL AND INFORMATION FOR GPS Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression Version:

More information

Fionnuala Plumart, Jade Tomes, Nick Rutherford Medicines Management Team, Brighton and Hove CCG

Fionnuala Plumart, Jade Tomes, Nick Rutherford Medicines Management Team, Brighton and Hove CCG Fionnuala Plumart, Jade Tomes, Nick Rutherford Medicines Management Team, Brighton and Hove CCG Why have we created this role? Processing 100 + repeat requests a day Constant phone ringing Many different

More information

Patient Group Directions Policy

Patient Group Directions Policy Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This

More information

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief.

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief. Prescribing paracetamol in adult inpatients at MEHT Type: Clinical Guideline Register No: 18005 Status: Public on ratification Developed in response to: In line with Basildon Contributes to CQC Outcome

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely

More information

July Formulary Policy

July Formulary Policy Formulary Policy July 2017 Responsible Committee: Quality Committee Date Effective: July 2017 Author: Rahinatu Amadu Supersedes: July 2016 Next Review Due: July 2018 Formulary Policy 2016-2018 1. INTRODUCTION

More information

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of

More information

Essential Shared Care Agreement: Lithium

Essential Shared Care Agreement: Lithium Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:

More information

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016 ljs7 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085

More information

Drug Therapy Following Bariatric Surgery

Drug Therapy Following Bariatric Surgery Drug Therapy Following Bariatric Surgery Linda F. McElhiney PharmD, RPh, MSP, FIACP, FACA, FASHP, DPLA Compounding Pharmacist Indiana University Health Disclosures Dr. McElhiney declare(s) no conflicts

More information

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical

More information

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire Healthcare NHS Foundation Trust Berkshire West Primary Care

More information

NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults. Consultation Group: See Page 5

NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults. Consultation Group: See Page 5 NHS...... Grampian Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults Co-ordinators: Consultant Anaesthetist, Lead Acute Pain

More information

Repeat Dispensing Handbook

Repeat Dispensing Handbook Repeat Dispensing Handbook For Sunderland Flow charts and quick reference guides for General Practice and Community Pharmacy No. Introduction 3 Training for Repeat Dispensing 4 Repeat Dispensing Champions

More information

PROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11. Administration

PROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11. Administration PROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11 NAME OF PROCEDURE: REASON FOR THE PROCEDURE: WHAT THE PROCEDURE WILL ACHIEVE: Medicines Procedure: Homely Remedies Administration Guidance on administration

More information

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

Paediatric Prescribing Pocket Guide September 2014 (Version 1) PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors

More information

Care Homes - Homely Remedies Protocol

Care Homes - Homely Remedies Protocol Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained

More information

D.O.C.U.M.E.N.T. classification system

D.O.C.U.M.E.N.T. classification system Drug-related problem Type Subtype Code Description Code Description D O C U M E N Drug selection D1 Duplication (Problems relating to the choice of drug prescribed or taken) D2 D3 D4 D5 D6 D7 D0 Drug interaction

More information

GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY

GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY First issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date August 2018 1.0 Promoting generic prescribing whenever

More information

Acute management of in-patient Parkinson s Disease patients

Acute management of in-patient Parkinson s Disease patients Acute management of in-patient Parkinson s Disease patients Contents Pages Introduction and Admission advice 2 Nil by Mouth Guidance 3 5 Complex therapy advice (Apomorphine, DBS, Duodopa) 6 Surgical peri-operative

More information

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document

More information

NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery

NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery Co-ordinators: Dr Karen Cranfield, Consultant Anaesthetist, Lead Acute Pain Sector

More information

patient group direction

patient group direction ASPIRIN v01 1/8 ASPIRIN PGD Details Version 1.0 Legal category P Staff grades Approved by Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)

More information

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults Co-ordinators: Medicines Information Pharmacist Consultation Group: See relevant page in guidance Approver: Medicine Guidelines

More information

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006) When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on www.nice.org.uk/cg032

More information

REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment.

REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment. Notes REGISTRATION ASSESSMENT SITTINGS 2018 Part 1 example questions 1. Questions 1 to 12 are examples from part 1 of the registration assessment. 2. The answers are on page 14. 3. Unless specified, give

More information

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE The Fijian Government invites expressions of interest from reputable Manufacturers and Suppliers for the supply

More information

Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures

Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures APper apc15-0avgfh7 Shared Care Guideline Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures For the latest information on interactions and adverse effects,

More information

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT Phosphate Binders for the Treatment of Hyperphosphataemia in adults with Chronic Kidney Disease OBJECTIVES To outline referral

More information

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines \ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents

More information

Expiry Date: September 2009 Template Version: Page 1 of 7

Expiry Date: September 2009 Template Version: Page 1 of 7 GG&C PGD ref 2007/467 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:

More information

LET - Maths, Stats & Numeracy

LET - Maths, Stats & Numeracy Metric Conversions Here are some metric weights arranged in size order, starting with the biggest:- Kg (kilogram) g (gram) mg (milligram) mcg (microgram) Each one is a thousand (1000) times smaller than

More information

Reviewing Medicines in at risk patients care homes

Reviewing Medicines in at risk patients care homes Reviewing Medicines in at risk patients care homes Clinical Medication Reviews by Pharmacists in Collaboration with GP Surgeries across Brighton and Hove CCG Liz Butterfield FRPharmS 19th April 2016 NICE:

More information

Mental Health Medicines Management Pilot. Community Pharmacy Lithium Support Service Guidance

Mental Health Medicines Management Pilot. Community Pharmacy Lithium Support Service Guidance Mental Health Medicines Management Pilot Community Pharmacy Lithium Support Service Guidance Approved Version 1 Date of First Issue Review Date Date of Issue Author / Contact Aaron Coulter Group / Committee

More information

PHARMACY INTERVENTION RECORD FORM 1.7 Medicine

PHARMACY INTERVENTION RECORD FORM 1.7 Medicine Date / /20 Pharmacist initials Ward Patient Demographics (as Hospital Number) Point Admissions (A) Care of the Elderly(CE) Respiratory (R) Gastroenterology(G) Rheumatology (Rh) Endocrine (E) Other (o)

More information

Understanding your take home medications from the surgical ward. Information for Patients

Understanding your take home medications from the surgical ward. Information for Patients Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for

More information

International initiatives on extemporaneous dispensing

International initiatives on extemporaneous dispensing Partners meeting WHO, Geneva 21 22 November 2011 International initiatives on extemporaneous dispensing Tony Nunn and Mark Turner UK Medicines for Children Research Network University of Liverpool Industry

More information

Berkshire West Area Prescribing Committee Guidance

Berkshire West Area Prescribing Committee Guidance Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for

More information

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010 Priority essential medicines: identifying products Dr Suzanne Hill September 2010 The problem looks like this Robertson, Forte, Trapsida & Hill. Bull WHO 2009 Robertson, Forte, Trapsida & Hill. Bull WHO

More information

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15. 90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.00 Allergy/Cold&Flu C-Phen Drops n/a Drops 90 $15.00 Allergy/Cold&Flu

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

Guide to Interchangeable Medicines

Guide to Interchangeable Medicines Guide to Interchangeable Medicines AUT-G0115-6 01 JUNE 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 BACKGROUND 3 1.1

More information

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011 POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE September 2011 WHSCT Policy for the safe use of oral methotrexate in secondary care Page 1 of 8 Policy Title Policy for the safe use of oral

More information

Procedure Reviewed By: Narinder Sangha Deputy Chief Pharmacist STANDARD OPERATING PROCEDURE

Procedure Reviewed By: Narinder Sangha Deputy Chief Pharmacist STANDARD OPERATING PROCEDURE Written By: Objective By: ed By: To ensure safe and consistent working practice throughout Black Country Partnership Foundation Trust (BCPFT) and to avoid unnecessary harm to patients on lithium therapy

More information

POLICY DOCUMENT. Pharmacy MMG/MPG. Approved By and Date Medicines Management roup March March 2016

POLICY DOCUMENT. Pharmacy MMG/MPG. Approved By and Date Medicines Management roup March March 2016 POLICY DOCUMENT Document Title High dose and combination antipsychotic guidance Reference Number n/a Policy Type Prescribing and Treatment Guideline Electronic File/Location Clinical Resources/Pharmacy/Prescribing

More information

PRSB e-discharge summary phase 2 Medications and medical devices information model

PRSB e-discharge summary phase 2 Medications and medical devices information model PRSB e-discharge summary phase 2 Medications and medical devices information model Purpose This paper provides an information model for medications and medical devices. It is based on the discharge summary

More information

Patient Group Direction (PGD) Supply of Nitrofurantoin for uncomplicated Urinary Tract Infections in females aged 16 years and over

Patient Group Direction (PGD) Supply of Nitrofurantoin for uncomplicated Urinary Tract Infections in females aged 16 years and over Patient Group Direction (PGD) Supply of Nitrofurantoin for uncomplicated Urinary Tract Infections in females aged 16 years and over Version Control This document is only valid on the day it was printed

More information

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing

More information

PHARMACY TECHNICIAN TRAINING COURSE Week #1

PHARMACY TECHNICIAN TRAINING COURSE Week #1 PHARMACY TECHNICIAN TRAINING COURSE Week #1 What we want to do this week: - Welcome! and complete some information on students - make sure we know how to use our calculators - learn about units and how

More information

Patient Group Directions (PGDs)

Patient Group Directions (PGDs) Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical

More information

PATIENT GROUP DIRECTIONS POLICY

PATIENT GROUP DIRECTIONS POLICY PATIENT GROUP DIRECTIONS POLICY To be read in conjunction with the Medicines Policy and the Controlled Drugs Policy Version: 5 Ratified by: Senior Managers Operations Group Date ratified: August 2015 October

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute

More information

DT Description Price Category Price change

DT Description Price Category Price change Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining

More information

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Aim Review and rationalise the insulin quantities based on dosage instructions for diabetic patients in order to align

More information

Coventry Health Care of Georgia, Inc.

Coventry Health Care of Georgia, Inc. Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan

More information

Policy for the safe use of oral methotrexate

Policy for the safe use of oral methotrexate Policy for the safe use of oral methotrexate Policy Checklist Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Does this meet criteria of a Policy? Staff side

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely remedy is a medicinal product

More information

Medicines Optimisation Strategy

Medicines Optimisation Strategy Clinical Reducing Dosing Errors with Opioid Medicines (Controlled Drug SOP): Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic

More information

All Saints First School Administering of Medicines Policy

All Saints First School Administering of Medicines Policy All Saints First School Administering of Medicines Policy Success Indicators The following indicators will demonstrate the level of compliance with this policy and its procedures: a) Employees who are

More information

HIGH DOSE ANTIPSYCHOTIC GUIDELINES (HDAT)

HIGH DOSE ANTIPSYCHOTIC GUIDELINES (HDAT) HIGH DOSE ANTIPSYCHOTIC GUIDELINES (HDAT) Document Reference Version Number 2.00 High Dose Antipsychotic Guidelines (HDAT) G376 Author/Lead Job Title Jackie Stark Principal Pharmacist Clinical Services

More information

Clinical Guideline Bone chemistry management in adult renal patients on dialysis

Clinical Guideline Bone chemistry management in adult renal patients on dialysis Clinical Guideline Bone chemistry management in adult renal patients on dialysis This guidance covers how to: Maintain serum phosphate 0.8 to 1.7mmol/L 1 Maintain serum corrected calcium 2.1 to 2.5mmol/L

More information

2015 Edition. Trust Medicines Formulary

2015 Edition. Trust Medicines Formulary 2015 Edition Trust Medicines Formulary Introduction Trust Medicines Formulary This formulary summarises all medicines used within the Trust, the Trust defines medicines as any substance, controlled or

More information

Medication Safety Presentation

Medication Safety Presentation Appendix E Aid 1: Sample Event Poster Medication Safety Presentation Do YOU know your role on the healthcare team? Do YOU know the questions to ask your pharmacist? Do YOU know safe medication practices?

More information

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP). Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath CCG) North East Hampshire & Farnham CCG and Crawley, Horsham & Mid-Sussex CCG Guidelines for the

More information

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Ca-C 1000 Calvive 1000 mg + 327 mg + 1000 mg effervescent tablets CALCIUM LACTATE GLUCONATE, CALCIUM CARBONATE, ASCORBIC ACID (VITAMIN C) This leaflet is a copy

More information

PPP 1. Continuation, modification, and discontinuation of a medication

PPP 1. Continuation, modification, and discontinuation of a medication PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

4WS Neurology. Table of Contents

4WS Neurology. Table of Contents 4WS Neurology Table of Contents 1. Phenytoin Preparations... Page 2 Monitoring... Page 2 Therapeutic Range... Page 2 Loading Doses... Page 2 Maintenance Doses... Page 3 Sampling Times... Page 3 Dose Adjustment...

More information

patient group direction

patient group direction SALBUTAMOL v01 1/12 SALBUTAMOL PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner

More information

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee Guidelines for the Management of Dyspepsia and GORD Document type: Version: 3.0 Author (name): Author (designation): Validated by Prescribing Dr. G. Lipscomb Date validated October 2015 Ratified by: Date

More information

Patient Group Direction (PGD)

Patient Group Direction (PGD) Patient Group Direction (PGD) Supply of Clarithromycin for Impetigo in patients aged one year and over who are allergic to Penicillin (Staffordshire Pharmacies Only) For the supply of Clarithromycin by

More information

PREFACE. Saskatchewan is participating in the Common Drug Review (CDR).

PREFACE. Saskatchewan is participating in the Common Drug Review (CDR). PREFACE OBJECTIVES The Drug Plan has been established to: provide coverage to Saskatchewan residents for quality pharmaceutical products of proven therapeutic effectiveness; reduce the direct cost of prescription

More information

Initiation of Clozapine Treatment Community Patients

Initiation of Clozapine Treatment Community Patients Initiation of Clozapine Treatment Community Patients Who Should Read This Policy Target Audience All clinical staff working in the community N/A N/A Initiation of Clozapine Treatment for Patients in the

More information

Babies 1500g. Caffeine citrate. Sodium Acid Phosphate (1mmol/ml) Ferrous Fumarate (Galfer 140mg/5ml) Infloran. Abidec BMF

Babies 1500g. Caffeine citrate. Sodium Acid Phosphate (1mmol/ml) Ferrous Fumarate (Galfer 140mg/5ml) Infloran. Abidec BMF Babies 1500g Infloran Caffeine citrate BMF Sodium Acid Phosphate (1mmol/ml) Abidec Ferrous Fumarate (Galfer 140mg/5ml) Dose Half capsule BD 10mg/kg once daily (write as caffeine citrate) 2% BMF each feed

More information

Synthroid interactions with food

Synthroid interactions with food Synthroid interactions with food The Borg System is 100 % Synthroid interactions with food You don't want to take ANY drugs or vitamins or supplements at the same time as you take your cream or milk is

More information

Over-the-counter medicines. Patient Information: Medicines. NHS Logo here. Working together for better patient information

Over-the-counter medicines. Patient Information: Medicines. NHS Logo here. Working together for better patient information Patient Information: Medicines NHS Logo here Over-the-counter medicines Health & care information you can trust The Information Standard Certified Member Working together for better patient information

More information

Governing Body meeting (held in public)

Governing Body meeting (held in public) ENCLOSURE: R Agenda Item: 154/16 Governing Body meeting (held in public) DATE: 24 November 2016 Title Community Pharmacy Medicines Waste Audit Report Summary 2016 This paper is for Information That the

More information

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015 Calgary Long Term Care Formulary Pharmacy & Therapeutics February 2015 Highlights http://www.albertahealthservices.ca/4070.aspx 1 Contents February 2016... 3 Added Product(s)... 3 Not Listed, Delisted

More information

SUMMARY OF SHARED CARE PROTOCOL FOR MYCOPHENOLATE MOFETIL (MMF)

SUMMARY OF SHARED CARE PROTOCOL FOR MYCOPHENOLATE MOFETIL (MMF) SUMMARY OF SHARED CARE PROTOCOL FOR MYCOPHENOLATE MOFETIL (MMF) Please refer to Chester Rheumatology shared care protocol for MMF and separate responsibilities document for full details. Responsibilities

More information

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations 49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a

More information